5-methyl-1-(naphthalen-2-yl)-1H-pyrazo les useful as sigma receptor inhibitors

Details for Australian Patent Application No. 2009239906 (hide)

Owner LABORATORIOS DEL DR. ESTEVE, S.A.

Inventors Bordas Gelabert, Maria Magdalena; Pretel Sanchez, Maria Jose; CuberesAltisent, Maria Rosa; Torrens Jover, Antoni

Agent Collison & Co

Pub. Number AU-A-2009239906

PCT Pub. Number WO2009/130331

Priority 08384005.8 25.04.08 EP

Filing date 27 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 231/22 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/5377 (2006.01)

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/130331 Priority application(s): WO2009/130331

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239927-Nalmefene di-ester prodrugs

2009239899-Process for treating waste from a membrane filtration plant